On this page
Evidence dossier
The report behind the claim
The investigators reported attenuation of injury measures and interactions with nitric-oxide modifiers. The experiment cannot establish safety of adding BPC-157 to an NSAID prescription.
Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME.
- Design
- Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
- Participants or model
- Rats exposed to a toxic experimental celecoxib regimen
- Endpoint
- Gastric, liver and brain lesions and liver enzymes
- Finding on record
- The investigators reported attenuation of injury measures and interactions with nitric-oxide modifiers.
- Limits of inference
- The experiment cannot establish safety of adding BPC-157 to an NSAID prescription.
The experiment in view
The study used rats exposed to a toxic experimental celecoxib regimen. Its principal measures were gastric, liver and brain lesions and liver enzymes. The investigators reported attenuation of injury measures and interactions with nitric-oxide modifiers.
Reading the result closely
A toxicity challenge is designed to produce measurable harm. The regimen and observation period do not represent an ordinary prescription discussion. The paper can support a mechanism question about drug injury while leaving the clinical combination, its risks and its potential effects on pain untested.
The boundary of the finding
The experiment cannot establish safety of adding BPC-157 to an NSAID prescription.
Related evidence, kept separate
BPC-157 during an ibuprofen-toxicity experiment examines gastric and liver injury, brain findings, enzymes and behavior. Here, the measured endpoint was gastric, liver and brain lesions and liver enzymes. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with The clopidogrel rat experiment: drug-related injury is not a combination recommendation appraisal.
On the record
The documents supporting this report.